Watch VideoPfizer's COVID-19 pill appears to provide little or no benefit for younger adults, while still reducing the risk of hospitalization and death for high-risk seniors, according to a large study published Wednesday.
The results from a 109,000-patient Israeli study are likely to renew questions about the U.S....
Study: Pfizer COVID Treatment Pill Showed No Benefit To Younger Adults
Newsy
0 shares
2 views
You might like
Related news coverage
Pfizer Covid pill showed no benefit in younger adults - study
New Zealand Herald
Pfizer's Covid-19 pill appears to provide little or no benefit for younger adults, while still reducing the risk of hospitalisation..